Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Alzheimer'S & Dementia (New York, N. Y.)|April 25, 2018
Alzheimer's disease Archimedes condition-event simulator: Development and validationAnuraag R Kansal, Ali Tafazzoli, K Jack Ishak, et al.
Dementia and Geriatric Cognitive Disorders Extra|May 29, 2018
The Economic Impact of New Therapeutic Interventions on Neuropsychiatric Inventory (NPI) Symptom Scores in Patients with Alzheimer DiseaseAli Tafazzoli, Anuraag Kansal, Peter Lockwood, et al.
Advances in Therapy|July 11, 2020
Efficiency Model of Cladribine Tablets Versus Infusion-Based Disease-Modifying Drugs for Patients with Relapsing-Remitting Multiple SclerosisAli Tafazzoli, Ameya Chavan, Gerard Harty, et al.
Neurology and Therapy|June 19, 2022
The Potential Economic Value of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation ModelingAmir Abbas Tahami Monfared, Ali Tafazzoli, Ameya Chavan, et al.
Neurology and Therapy|April 26, 2022
Long-Term Health Outcomes of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation ModelingAmir Abbas Tahami Monfared, Ali Tafazzoli, Weicheng Ye, et al.
Journal of the International AIDS Society|November 14, 2014
Cost-effectiveness of DTG+ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United StatesSiyang Peng, Ali Tafazzoli, Emily Dorman, et al.
Journal of Medical Economics|May 3, 2015
Cost-effectiveness of DTG + ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United StatesSiyang Peng, Ali Tafazzoli, Emily Dorman, et al.
JAMA Network Open|October 22, 2021
Evaluation of the Cost-effectiveness of Drug Treatment for Alzheimer Disease in a Simulation Model That Includes Caregiver and Societal FactorsKouta Ito, Rick Chapman, Steven D Pearson, et al.
Journal of the American Heart Association|February 16, 2024
Cost-Effectiveness Analysis of Empagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction in the United StatesOdette S Reifsnider, Ali Tafazzoli, Stephan Linden, et al.
Neurology and Therapy|August 12, 2022
A Simulation Model to Evaluate the Potential Impact of Disease-Modifying Treatments on Burden of Illness in Alzheimer's DiseaseAmir Abbas Tahami Monfared, Ali Tafazzoli, Weicheng Ye, et al.
Pageof 2